**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 1306-19-0 |Cadmium oxide, brown | 99 | 215-146-2 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 22 49 48/23/25
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. May cause cancer by inhalation. Toxic : danger
of serious damage to health by prolonged exposure through inhalation
and if swallowed.Toxic.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Harmful if swallowed.
Inhalation:
Harmful if inhaled.
Chronic:
Chronic exposure may cause reproductive disorders and teratogenic
effects. Cadmium and compounds may cause lung, liver and kidney
damage and lung and prostate cancer in humans. Potential cancer
hazard.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do not use
mouth-to-mouth resuscitation if victim ingested or inhaled the
substance; induce artificial respiration with the aid of a pocket
mask equipped with a one-way valve or other proper respiratory
medical device.
Notes to Physician:
Persons with skin problems or liver, kidney, lung, or blood diseases
may be at increased risk from exposure to this substance. Treat
symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up, then place into a suitable container for disposal. Avoid
generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Do not ingest or inhale. Do
not breathe dust.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances. Keep containers tightly closed.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 1306-19-0:
United Kingdom, WEL - TWA: 0.025 mg/m3 TWA (fume)
United Kingdom, WEL - STEL: 0.05 mg/m3 STEL (fume)
United States OSHA: 2.5 ??g/m3 Action Level (as Cd); 5 ??g/m3 PEL (
Cd. Do not eat, drink or chew t obacco or gum or apply cosmetics
regulated areas. Carcinogen: dust can cause lung and kidney
disease. See 29 CFR 1910.1027) (listed under Cadmium compounds).
Belgium - TWA: (listed as cadmium compounds): 0.002 mg/m3 VLE
(respirable particulates, as Cd); 0.01 mg/m3 VLE (inhalable part
France - VME: (listed as cadmium compounds): 0.05 mg/m3 VME (as C
France - VLE: 0.05 mg/m3 VLE (as Cd)
Germany: (listed as cadmium compounds): 0.05 mg/m3 VME (as Cd)
Japan: (listed as cadmium compounds): 0.05 mg/m3 OEL (as Cd)
Malaysia: (listed as cadmium compounds): 0.01 mg/m3 TWA (as Cd);
0.002 mg/m3 TWA (respirable fraction, as Cd)
Russia: (listed as cadmium compounds): 0.05 mg/m3 TWA (as Cd)
Russia: (listed as cadmium compounds): 0.01 mg/m3 STEL (as Cd)
Spain: 0.01 mg/m3 VLA-ED (inhalable fraction, as Cd); 0.002 mg/m3
VLA-ED (respirable fr
Personal Protective Equipment
Eyes:
Wear safety glasses and chemical goggles if splashing
is possible.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149
approved full-facepiece airline respirator in the
positive pressure mode with emergency escape
provisions.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: red-brown
Odor: odorless
pH: Not available.
Vapor Pressure: 1 mm Hg @ 1000 deg C
Viscosity: Not available.
Boiling Point: 1385 deg C @ 760.00mmHg
Freezing/Melting Point: decomp @ 950 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: > 900 deg C
Solubility in water: practically insoluble in water
Specific Gravity/Density: 8.15 g/cm3
Molecular Formula: CdO
Molecular Weight: 128.40
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. May discolor on
exposure to light.
Conditions to Avoid:
Incompatible materials, light, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents, magnesium.
Hazardous Decomposition Products:
Cadmium fumes.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1306-19-0: EV1925000
LD50/LC50:
CAS# 1306-19-0: Inhalation, mouse: LC50 = 250 mg/m3/2H; Inhalation,
rabbit: LC50 = 2500 mg/m3/10M; Inhalation, rat: LC50 = 45 mg/m3/1H;
Oral, mouse: LD50 = 67 mg/kg; Oral, rat: LD50 = 72 mg/kg.
Carcinogenicity:
Cadmium oxide, brown -
California: carcinogen, initial date 10/1/87 (listed as Cadmium compou
NTP: Known carcinogen (listed as Cadmium compounds).
IARC: Group 1 carcinogen (listed as Cadmium compounds).
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: CADMIUM COMPOUND
Hazard Class: 6.1
UN Number: 2570
Packing Group: III
IMO
Shipping Name: CADMIUM COMPOUND
Hazard Class: 6.1
UN Number: 2570
Packing Group: III
RID/ADR
Shipping Name: CADMIUM COMPOUND
Hazard Class: 6.1
UN Number: 2570
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 49 May cause cancer by inhalation.
R 22 Harmful if swallowed.
R 48/23/25 Toxic : danger of serious damage to
health by prolonged exposure through inhalation and if
swallowed.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 1306-19-0: 3
Canada
CAS# 1306-19-0 is listed on Canada's DSL List.
CAS# 1306-19-0 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1306-19-0 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
3-Hydroxy-4-Methoxycinnamic Acid, 97%, Predominantly Trans
| 537-73-5 |
|
4'-Methoxypropiophenone, 99%
| 121-97-1 |
|
L-Thyroxine, 99%
| 51-48-9 |
|
Cholesteryl Propionate
| 633-31-8 |
|
Benzoin methyl ether, 93% (hplc)
| 3524-62-7 |
|
Cadmium oxide, brown, 99%
| 1306-19-0 |
|
4-Chlorobutyronitrile, 98+%
| 628-20-6 |
|
2-Chloro-6-Methyl-3-Pyridinecarboxylic Acid, 99+%
| 30529-70-5 |
|
bis(2-Ethylhexyl) sebacate, 97+% (gc)
| 122-62-3 |
|
Tween 60
| 9005-67-8 |
|
3,3'-Carbonylbis(7-Diethylaminocoumarin), 99% (UV-Vis)
| 63226-13-1 |
|
1-Naphthoic acid, 98%
| 86-55-5 |
|
4-Ethylanisole, 99%
| 1515-95-3 |
|
3-(Diethylamino)propionitrile 98%
| 5351-04-2 |
|
4-Hydroxydiphenylmethane, 96%
| 101-53-1 |
|
Heptanoic Acid
| 111-14-8 |
|
Diisobutylaluminum hydride, 20 wt.% solution in toluene
| 108-88-3 |
|
trans-Methyl crotonate, 98%
| 623-43-8 |
|
(1R)-Cis-Chrysanthemylamine Hydrochloride 95%
| 0-01-1 |
|
1-Hydroxy-6-Methylsulphonylindole, 95+%
| |
|
Direct black 22
| 6473-13-8 |
|
N-Heptyl-Triphenylphosphonium Bromide, 99%
| 13423-48-8 |
|
Hexamethyldisiloxane, 98+%
| 107-46-0 |
|
2-Nonanol, 99%
| 628-99-9 |
|
(S)-(+)-Phenylsuccinic Acid, 99+%
| 4036-30-0 |
|
1,4-Diiodobutane, 98%
| 628-21-7 |
|
Methyl 1-Methoxybicyclo(2.2.2)oct-5-ene-2- Carboxylate, 98%
| 5259-50-7 |
|
Trichloroacetyl isocyanate
| 3019-71-4 |
|
Methyl sulfone, 98%
| 67-71-0 |
|
Coralyne Chloride, Hydrate, 98+%
| 38989-38-7 |
|
1,2,3,4-Tetraphenyl-1,3-cyclopentadiene, 98%
| 15570-45-3 |
|
4-Bromofluorobenzene, 99%
| 460-00-4 |
|
Vinyltriacetoxysilane, monomer, 90%
| 4130-08-9 |
|
1,1-Dimethoxyethane, 95% (gc)
| 534-15-6 |
|
Azure B Eosinate
| 62298-42-4 |
|
O-Methylisourea Hemisulfate, 94%
| 52328-05-9 |
|
5-Bromo-DL-Tryptophan, 99%
| 6548-09-0 |
|
n-Methyl-2-nitroaniline, 98%
| 612-25-9 |
|
1-(3-Chlorophenyl)-4-(3-Chloropropyl)piperazine Hydrochloride,
| 39577-43-0 |
|
3-Benzoylpropionic Acid, 98%
| 2051-95-8 |
|
Mercury Cyclohexanebutyrate
| 62638-02-2 |
|
4-Chloro-1-[4-(1,1-Dimethylethyl)Phenyl]-1-Butanone, 98+% (GC)
| 43076-61-5 |
|
Butyl Formate, 98% (GC)
| 592-84-7 |
|
5-Hydroxy-p-naphthoquinone, 97%
| 481-39-0 |
|
11alpha-Hydroxy-17alpha-methyltestosterone
| 1043-10-3 |
|
MBD
| 33984-50-8 |
|
Mucochloric acid, 99%(titr.,dry substance)
| 87-56-9 |
|
N-Alpha-Acetyl-L-Lysine, 99+%
| 1946-82-3 |
|
Vanadyl phthalocyanine (pract)
| 13930-88-6 |
|
(2R,3S)-1-Carboxy-4-Ethyl-2,3-Dihydroxy-Cyclohexa-4,6-Diene, Sodium
| 0-01-1 |
|
|